As part of general management instructions, you will be responsible for medico-scientific content and strategies as well as for the associated procedures and decisions required for successful marketing of medicinal products for the treatment of cancer in a competitive market, accounting for the prevailing framework conditions (e.g. laws, codes, etc.). Furthermore you are acting as an ambassador for the R&D activities and the scientific profile of the company. As a result of you strong experiences regarding clinical research, you will identify potential partners for the preclinical and clinical development (phase III) of an innovative drug for the treatment of patients with AML. You will discuss, plan, initiate and support pre-clinical and clinical studies with potential partners regarding all governmental restrictions, laws, policies and guidelines. In doing this you will use your reliable contacts to oncology research centers and medical centers of excellence and you high-level knowledge of GCP and GLP guidelines. At the same time you represent the company's existing medical expertise in the field of oncological diseases and are the point of contact for in-house and external agencies.